Using nanoparticles to target fibrosis in cancer and other diseases
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Using nanoparticles to target fibrosis in cancer and other diseases
UK government announces 'National Cancer Board’ to drive improvements in cancer care
FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma
Can your breath help diagnose lung cancer?
Researchers use computational design to engineer immune cells to fight cancer and viruses
Hundreds of chemicals used in pesticides linked to increased breast cancer risk
Targeting ZMYND8 improves T-cell function and may boost immunotherapy
Scientists uncover an Achilles’ heel in cancer’s ‘rogue DNA’
Low faecal elastase in immunotherapy diarrhoea may reflect dilution, not pancreatic insufficiency
FDA approves taletrectinib for ROS1-positive non-small cell lung cancer
Physician warmth and competence may help patients worry less over normal test results
Blood vessel features in tumours may help predict patient survival in colorectal cancer